Harvard Bioscience Inc (HBIO) stock
HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.08+0.17 (+1.91%)
Close on Nov 17, 2026Market cap $41.33MP/E –Yield –
Harvard Bioscience total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Harvard Bioscience's total debt was $36.68M at Jun 30, 2026. For fiscal 2025 it was $35.87M, down 2.9% from the year before. Over ten years it grew 8.2% a year on average. The highest annual figure on record is $57.21M in fiscal 2018.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.87M | -2.9% |
| FY2024 | Dec 31, 2024 | $36.96M | +0.3% |
| FY2023 | Dec 31, 2023 | $36.84M | -21.8% |
| FY2022 | Dec 31, 2022 | $47.10M | -3.1% |
| FY2021 | Dec 31, 2021 | $48.61M | +0.7% |
| FY2020 | Dec 31, 2020 | $48.29M | -3.7% |
| FY2019 | Dec 31, 2019 | $50.12M | -12.4% |
| FY2018 | Dec 31, 2018 | $57.21M | +536.9% |
| FY2017 | Dec 31, 2017 | $8.98M | -21.0% |
| FY2016 | Dec 31, 2016 | $11.37M | -30.5% |
| FY2015 | Dec 31, 2015 | $16.37M | -0.5% |
| FY2014 | Dec 31, 2014 | $16.45M | -16.7% |
| FY2013 | Dec 31, 2013 | $19.75M | +52.5% |
| FY2012 | Dec 31, 2012 | $12.95M | -20.6% |
| FY2011 | Dec 31, 2011 | $16.30M | -9.5% |
| FY2010 | Dec 31, 2010 | $18.01M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $36.68M | -4.1% |
| Q1 FY2026 | Mar 31, 2026 | $36.21M | +0.7% |
| Q4 FY2025 | Dec 31, 2025 | $35.87M | -0.1% |
| Q4 FY2024 | Dec 31, 2024 | $36.96M | +0.3% |
| Q3 FY2024 | Sep 30, 2024 | $38.25M | -2.0% |
| Q2 FY2024 | Jun 30, 2024 | $35.96M | -13.8% |
| Q1 FY2024 | Mar 31, 2024 | $35.89M | -19.0% |
| Q4 FY2023 | Dec 31, 2023 | $36.84M | -21.8% |
| Q3 FY2023 | Sep 30, 2023 | $39.02M | -21.2% |
| Q2 FY2023 | Jun 30, 2023 | $41.70M | -14.5% |
| Q1 FY2023 | Mar 31, 2023 | $44.33M | -10.0% |
| Q4 FY2022 | Dec 31, 2022 | $47.10M | -3.1% |
| Q3 FY2022 | Sep 30, 2022 | $49.53M | +8.9% |
| Q2 FY2022 | Jun 30, 2022 | $48.76M | +12.3% |
| Q1 FY2022 | Mar 31, 2022 | $49.24M | +12.3% |
| Q4 FY2021 | Dec 31, 2021 | $48.61M | +0.7% |
| Q3 FY2021 | Sep 30, 2021 | $45.49M | +3.7% |
| Q2 FY2021 | Jun 30, 2021 | $43.42M | -1.6% |
| Q1 FY2021 | Mar 31, 2021 | $43.85M | -11.4% |
| Q4 FY2020 | Dec 31, 2020 | $48.29M | -3.7% |
| Q3 FY2020 | Sep 30, 2020 | $43.87M | -15.2% |
| Q2 FY2020 | Jun 30, 2020 | $44.12M | -15.8% |
| Q1 FY2020 | Mar 31, 2020 | $49.48M | -8.6% |
| Q4 FY2019 | Dec 31, 2019 | $50.12M | -12.4% |
| Q3 FY2019 | Sep 30, 2019 | $51.71M | -12.7% |
| Q2 FY2019 | Jun 30, 2019 | $52.41M | -12.4% |
| Q1 FY2019 | Mar 31, 2019 | $54.14M | -12.1% |
| Q4 FY2018 | Dec 31, 2018 | $57.21M | +536.9% |
| Q3 FY2018 | Sep 30, 2018 | $59.25M | +512.4% |
| Q2 FY2018 | Jun 30, 2018 | $59.83M | +474.3% |
| Q1 FY2018 | Mar 31, 2018 | $61.57M | +463.3% |
| Q4 FY2017 | Dec 31, 2017 | $8.98M | -21.0% |
| Q3 FY2017 | Sep 30, 2017 | $9.67M | -23.6% |
| Q2 FY2017 | Jun 30, 2017 | $10.42M | – |
| Q1 FY2017 | Mar 31, 2017 | $10.93M | – |
| Q4 FY2016 | Dec 31, 2016 | $11.37M | – |
| Q3 FY2016 | Sep 30, 2016 | $12.67M | – |
See a number that looks wrong?